Technology | 2020.06.03
QCDx Announces Clinical Study for the Determination of Clinical Utility of the QCDx-br™ Liquid Biopsy System to Optimize Treatment Options for Breast Cancer
QCDx’s technology provides in-depth information for early cancer diagnosis, optimization and monitoring efficacy of treatment and early detection of disease recurrence
(PRWeb June 03, 2020)
Read the full story at https://www.prweb.com/releases/qcdx_announces_clinical_study_for_the_determination_of_clinical_utility_of_the_qcdx_br_liquid_biopsy_system_to_optimize_treatment_options_for_breast_cancer/prweb17165406.htm
For more information, please visit
https://www.prweb.com/releases/qcdx_anno[...]reast_cancer/prweb17165406.htm
